$37 Million is the total value of Ridgeback Capital Investments L.P.'s 1 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KPTI | New | KARYOPHARM THERAPEUTICS INC. | $36,967,000 | – | 3,945,200 | +100.0% | 100.00% | – |
Exit | 00 | $0 | – | 0 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
0 | 29 | Q3 2023 | 0.0% |
0 | 8 | Q2 2015 | 0.0% |
BICYCLE THERAPEUTICS INC. | 2 | Q4 2022 | 80.4% |
APPLIED GENETIC TECHNOLOGIES INC. | 2 | Q4 2015 | 100.0% |
CELLDEX THERAPEUTICS INC | 2 | Q4 2013 | 74.6% |
AFFIMED NV | 2 | Q4 2022 | 23.2% |
F-STAR THERAPEUTICS INC. | 2 | Q4 2022 | 5.0% |
KARYOPHARM THERAPEUTICS INC. | 1 | Q4 2018 | 100.0% |
SANGAMO BIOSCIENCES INC | 1 | Q4 2013 | 50.9% |
CARA THERAPEUTICS, INC. | 1 | Q4 2015 | 45.1% |
View Ridgeback Capital Investments L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
F-star Therapeutics, Inc. | February 14, 2023 | 52,509 | 0.2% |
Cogent Biosciences, Inc. | February 14, 2022 | ? | ? |
4D Molecular Therapeutics Inc. | February 16, 2021 | 1,100,000 | 4.2% |
MYOMO, INC. | February 16, 2021 | 104,755 | 2.3% |
SUTRO BIOPHARMA, INC. | February 16, 2021 | 1,144,979 | 2.5% |
Verastem, Inc. | February 16, 2021 | ? | ? |
Unum Therapeutics Inc. | July 16, 2020 | 2,400,000 | 6.2% |
Karyopharm Therapeutics Inc. | February 14, 2020 | ? | ? |
Spring Bank Pharmaceuticals, Inc. | January 06, 2020 | 1,142,900 | 6.9% |
Corium International, Inc. | March 15, 2018 | 1,914,265 | 5.2% |
View Ridgeback Capital Investments L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-01-26 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
View Ridgeback Capital Investments L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.